Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...
Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...
Multiple sclerosis is an autoimmune condition where, for reasons scientists are still trying to understand, your body’s immune system suddenly attacks the coating covering the nerves in your brain and ...
After Judith Harding was diagnosed with multiple myeloma in 2009, she decided to retire, sold her condo, dropped out of her PhD program and moved nearer to her family, preparing to "live out my last ...
Multiple sclerosis is a chronic disease where your immune system starts attacking your brain and spinal cord. The number of people living with the condition has grown to 913,925—current estimates ...
Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed down ...
At age 89, Cal Crow plays water volleyball three days a week, then chases that with a 1,000-foot swim; on his off days, he logs at least a mile around his neighborhood — and that’s with a cancer ...
Your risk for multiple myeloma (MM) increases as you age. In fact, 35% of the patients are diagnosed at age 75 or older, including 10% who are 85 or older. The average age for this type of blood ...
One question that team members at my company, a boutique investment bank that provides merger-and-acquisition and capital-advisory services, have been fielding lately from both current and prospective ...
In the stock market, there are far more moving pieces than some beginners may think. For instance, the price of a stock is dependent on a variety of variables. Fortunately, they can be easily ...
The blood cancer multiple myeloma, which involves infection-fighting plasma cells in the bone marrow, affects only about 1% of all cancers -- predominantly individuals over age 65. The disease ...